(Q66082435)
Statements
A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease (English)
0 references
17 October 2016
0 references
30 April 2021
0 references
400
0 references
55 year
0 references
85 year
0 references